N-methyl-6-(2-methylindazol-5-yl)-N-piperidin-4-yl-[1,3]thiazolo[4,5-b]pyridin-2-amine;hydrochloride
C20H23ClN6S — CID 153383564
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-methyl-6-(2-methylindazol-5-yl)-N-piperidin-4-yl-[1,3]thiazolo[4,5-b]pyridin-2-amine;hydrochloride
N-methyl-6-(2-methylindazol-5-yl)-N-piperidin-4-yl-[1,3]thiazolo[4,5-b]pyridin-2-amine;hydrochloride (PubChem CID 153383564) has the molecular formula C20H23ClN6S and a molecular weight of 414.97 g/mol. Its IUPAC name is N-methyl-6-(2-methylindazol-5-yl)-N-piperidin-4-yl-[1,3]thiazolo[4,5-b]pyridin-2-amine;hydrochloride.
Molecular Properties
| Compound Name | N-methyl-6-(2-methylindazol-5-yl)-N-piperidin-4-yl-[1,3]thiazolo[4,5-b]pyridin-2-amine;hydrochloride |
|---|---|
| PubChem CID | 153383564 |
| Molecular Formula | C20H23ClN6S |
| Molecular Weight | 414.97 g/mol |
| Exact Mass | 414.14 |
| IUPAC Name | N-methyl-6-(2-methylindazol-5-yl)-N-piperidin-4-yl-[1,3]thiazolo[4,5-b]pyridin-2-amine;hydrochloride |
| SMILES | CN(c1nc2ncc(-c3ccc4nn(C)cc4c3)cc2s1)C1CCNCC1.Cl |
| InChI | InChI=1S/C20H22N6S.ClH/c1-25-12-15-9-13(3-4-17(15)24-25)14-10-18-19(22-11-14)23-20(27-18)26(2)16-5-7-21-8-6-16;/h3-4,9-12,16,21H,5-8H2,1-2H3;1H |
| InChIKey | OBYJAWPSWQBUNL-UHFFFAOYSA-N |
| XLogP | 3.86 |
| TPSA | 58.87 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 414.97 |
| LogP ≤ 5 | 3.86 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153383564 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.